$2500 | Single User
$5000 | Site License
$7500 | Enterprise License

Ebolavirus Infections (Ebola Hemorrhagic Fever) Global Clinical Trials Review, H2, 2016
[Published by Global Data]

Published by Global Data: 30 Sep 2016 | 27704 | In Stock
Related Topics: Clinical Trials

Introduction

Ebolavirus Infections (Ebola Hemorrhagic Fever) Global Clinical Trials Review, H2, 2016

Summary

GlobalData's clinical trial report, “Ebolavirus Infections (Ebola Hemorrhagic Fever) Global Clinical Trials Review, H2, 2016" provides an overview of Ebolavirus Infections (Ebola Hemorrhagic Fever) clinical trials scenario. This report provides top line data relating to the clinical trials on Ebolavirus Infections (Ebola Hemorrhagic Fever). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape

- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

- The Report provides enrollment trends for the past five years

- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment

- Helps in identifying prominent locations for conducting clinical trials which saves time and cost

- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

- Supports understanding of trials count and enrollment trends by country in global therapeutics market

- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents
for Ebolavirus Infections (Ebola Hemorrhagic Fever) Global Clinical Trials Review, H2, 2016 [Published by Global Data]

  • Table of Contents

    Table of Contents 2

    List of Tables 3

    List of Figures 4

    Report Guidance 5

    Clinical Trials by Region 6

    Clinical Trials and Average Enrollment by Country 7

    Top Countries Contributing to Clinical Trials in Asia-Pacific 10

    Top Five Countries Contributing to Clinical Trials in Europe 11

    Top Countries Contributing to Clinical Trials in North America 12

    Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13

    Clinical Trials by G7 Countries: Proportion of Ebolavirus Infections (Ebola Hemorrhagic Fever) to Infectious Disease Clinical Trials 14

    Clinical Trials by Phase in G7 Countries 16

    Clinical Trials in G7 Countries by Trial Status 17

    Clinical Trials by E7 Countries: Proportion of Ebolavirus Infections (Ebola Hemorrhagic Fever) to Infectious Disease Clinical Trials 18

    Clinical Trials in E7 Countries by Trial Status 20

    Clinical Trials by Phase 21

    In Progress Trials by Phase 22

    Clinical Trials by Trial Status 23

    Clinical Trials by End Point Status 24

    Subjects Recruited Over a Period of Time 25

    Clinical Trials by Sponsor Type 26

    Prominent Sponsors 27

    Top Companies Participating in Ebolavirus Infections (Ebola Hemorrhagic Fever) Therapeutics Clinical Trials 28

    Prominent Drugs 30

    Latest Clinical Trials News on Ebolavirus Infections (Ebola Hemorrhagic Fever) 31

    Oct 04, 2016: RespireRx Pharmaceuticals Retracts Efficacy Data in September 12, 2016 Press Release Announcing Preliminary Top-Line Analysis of Safety and Efficacy Data from Duke University Phase 2A Clinical Trial of CX 1739 31

    Sep 07, 2016: BioCryst Announces Positive Study Results for BCX4430 Delayed Treatment of Ebola Virus Infection in a Non-Human Primate Model 31

    Aug 24, 2016: Experts at World Congress of Internal Medicines Reinforce Importance of BETADINE in Disease Prevention, Infection Control and Oral Mucositis Treatment 31

    Aug 11, 2016: Inovio Pharmaceuticals Expands Positive Phase I Ebola Vaccine Trial to Identify Most Optimal Immunization Regimen 32

    Jul 28, 2016: Ranpirnase Shows Antiviral Effect Against Ebola 33

    Jul 18, 2016: Soligenix Announces Presentation of Positive Preliminary Results of a Heat Stable Ebola Vaccine Formulation 33

    Jul 14, 2016: Yisheng Biopharma and the United States Army Medical Research Institute of Infectious Diseases Announce Positive Animal Results of Vaccine Against Ebola Virus 35

    Clinical Trial Profile Snapshots 36

    Appendix 88

    Abbreviations 88

    Definitions 88

    Research Methodology 89

    Secondary Research 89

    About GlobalData 90

    Contact Us 90

    Disclaimer 90

    Source 91

List Of Tables
in Ebolavirus Infections (Ebola Hemorrhagic Fever) Global Clinical Trials Review, H2, 2016 [Published by Global Data]

List of Tables

Ebolavirus Infections (Ebola Hemorrhagic Fever) Therapeutics, Global, Clinical Trials by Region, 2016* 6

Ebolavirus Infections (Ebola Hemorrhagic Fever) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 8

Ebolavirus Infections (Ebola Hemorrhagic Fever) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 9

Ebolavirus Infections (Ebola Hemorrhagic Fever) Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2016* 10

Ebolavirus Infections (Ebola Hemorrhagic Fever) Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 11

Ebolavirus Infections (Ebola Hemorrhagic Fever) Therapeutics Clinical Trials, North America, Top Countries, 2016* 12

Ebolavirus Infections (Ebola Hemorrhagic Fever) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2016* 13

Proportion of Ebolavirus Infections (Ebola Hemorrhagic Fever) to Infectious Disease Clinical Trials, G7 Countries (%), 2016* 15

Ebolavirus Infections (Ebola Hemorrhagic Fever) Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 16

Ebolavirus Infections (Ebola Hemorrhagic Fever) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 17

Proportion of Ebolavirus Infections (Ebola Hemorrhagic Fever) to Infectious Disease Clinical Trials, E7 Countries (%), 2016* 19

Ebolavirus Infections (Ebola Hemorrhagic Fever) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 20

Ebolavirus Infections (Ebola Hemorrhagic Fever) Therapeutics, Global, Clinical Trials by Phase, 2016* 21

Ebolavirus Infections (Ebola Hemorrhagic Fever) Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 22

Ebolavirus Infections (Ebola Hemorrhagic Fever) Therapeutics, Global, Clinical Trials by Trial Status, 2016* 23

Ebolavirus Infections (Ebola Hemorrhagic Fever) Therapeutics Clinical Trials, Global, by End Point Status, 2016* 24

Ebolavirus Infections (Ebola Hemorrhagic Fever) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 25

Ebolavirus Infections (Ebola Hemorrhagic Fever) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 26

Ebolavirus Infections (Ebola Hemorrhagic Fever) Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 27

Ebolavirus Infections (Ebola Hemorrhagic Fever) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 29

Ebolavirus Infections (Ebola Hemorrhagic Fever) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 30

List Of Figures, Charts and Diagrams
in Ebolavirus Infections (Ebola Hemorrhagic Fever) Global Clinical Trials Review, H2, 2016 [Published by Global Data]

List of Figures

Ebolavirus Infections (Ebola Hemorrhagic Fever) Therapeutics, Global, Clinical Trials by Region (%), 2016* 6

Ebolavirus Infections (Ebola Hemorrhagic Fever) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7

Ebolavirus Infections (Ebola Hemorrhagic Fever) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 9

Ebolavirus Infections (Ebola Hemorrhagic Fever) Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2016* 10

Ebolavirus Infections (Ebola Hemorrhagic Fever) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 11

Ebolavirus Infections (Ebola Hemorrhagic Fever) Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 12

Ebolavirus Infections (Ebola Hemorrhagic Fever) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2016* 13

Proportion of Ebolavirus Infections (Ebola Hemorrhagic Fever) to Infectious Disease Clinical Trials, G7 Countries (%), 2016* 14

Ebolavirus Infections (Ebola Hemorrhagic Fever) Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 16

Ebolavirus Infections (Ebola Hemorrhagic Fever) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 17

Proportion of Ebolavirus Infections (Ebola Hemorrhagic Fever) to Infectious Disease Clinical Trials, E7 Countries (%), 2016* 18

Ebolavirus Infections (Ebola Hemorrhagic Fever) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 20

Ebolavirus Infections (Ebola Hemorrhagic Fever) Therapeutics, Global, Clinical Trials by Phase (%), 2016* 21

Ebolavirus Infections (Ebola Hemorrhagic Fever) Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 22

Ebolavirus Infections (Ebola Hemorrhagic Fever) Therapeutics, Global, Clinical Trials by Trial Status, 2016* 23

Ebolavirus Infections (Ebola Hemorrhagic Fever) Therapeutics Clinical Trials, Global, by End Point Status, 2016* 24

Ebolavirus Infections (Ebola Hemorrhagic Fever) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 25

Ebolavirus Infections (Ebola Hemorrhagic Fever) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 26

Ebolavirus Infections (Ebola Hemorrhagic Fever) Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 27

Ebolavirus Infections (Ebola Hemorrhagic Fever) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 28

Ebolavirus Infections (Ebola Hemorrhagic Fever) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 30

GlobalData Methodology 89

Additional Details

Publisher

Global Data

Publisher Information

Reference

27704 | GDHC3798CTIDB

Number of Pages

91

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Ebolavirus Infections (Ebola Hemorrhagic Fever) - Pipeline Review, H1 2018
Ebolavirus Infections (Ebola Hemorrhagic Fever) - Pipeline Review, H1 2018SummaryGlobal Markets Dire...
13 Mar 2018 by Global Markets Direct USD $2,000 More Info
Ebolavirus Infections (Ebola Hemorrhagic Fever) Global Clinical Trials Review, H2, 2017
Ebolavirus Infections (Ebola Hemorrhagic Fever) Global Clinical Trials Review, H2, 2017SummaryGlobal...
31 Jul 2017 by Global Data USD $2,500 More Info
Ebolavirus Infections (Ebola Hemorrhagic Fever) - Pipeline Review, H1 2017
Ebolavirus Infections (Ebola Hemorrhagic Fever) - Pipeline Review, H1 2017SummaryGlobal Markets Dire...
31 Mar 2017 by Global Markets Direct USD $2,000 More Info
Ebolavirus Infections (Ebola Hemorrhagic Fever) - Pipeline Review, H2 2016
Ebolavirus Infections (Ebola Hemorrhagic Fever) - Pipeline Review, H2 2016SummaryGlobal Markets Dire...
23 Nov 2016 by Global Markets Direct USD $2,000 More Info

This report is published by Global Data

Download Free Report Summary PDF

Ebolavirus Infections (Ebola Hemorrhagic Fever) Global Clinical Trials Review, H2, 2016 [Published by Global Data] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...